Fundación Gecp

This study tested an immunotherapy drug called M7824 for people with advanced mesothelioma that had worsened after standard chemotherapy. 47 patients received the drug through an IV every two weeks to see if it could slow tumor growth and was safe to use. The main goal was to mea…

This study tested a combination of two immunotherapy drugs, atezolizumab and bevacizumab, as a first treatment for people with a specific type of advanced non-small cell lung cancer. The main goal was to see how long the treatment could keep the cancer from getting worse. The tri…

This study aimed to understand how lung cancer and its treatment affect patients' sexual health. Researchers observed over 550 patients to learn how common and severe these problems are. The goal is to use this information to create better support and follow-up care for future pa…

This study aimed to understand how people with lung cancer develop and maintain immunity after getting COVID-19 or receiving a COVID-19 vaccine. Researchers observed nearly 2,000 patients across Spain, checking their blood for protective antibodies at different times. The goal wa…